Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Regenerative medicine, particularly adipose-derived stem cell therapy, is gaining attention as a forward-thinking approach to health and wellness. By harnessing the body’s own repair mechanisms, this treatment offers potential for addressing various concerns related to aging and inflammation. However, it’s crucial to understand that the outcomes of stem cell therapy are not uniform for everyone. The response to treatment can vary significantly from one person to another. This article explores the science-based factors that can influence your treatment outcome, helping you form realistic expectations about what regenerative medicine may offer.
Understanding Why Stem Cell Therapy Outcomes Differ
The primary reason for variability in stem cell therapy outcomes lies in our unique biological individuality. The effectiveness of the therapy is influenced by a complex interplay of personal factors, including age, overall health, lifestyle, and the specific condition being addressed. This variability is not a sign of treatment failure but rather a reflection of how personalized medicine works. Your body’s internal environment dictates how it responds to the introduction of cultured stem cells. Recognizing this from the outset is key to navigating your treatment journey with a clear perspective.
Key Factors That Influence Treatment Efficacy
Several well-documented factors can affect the results of adipose-derived stem cell therapy. A thorough understanding of these elements is essential for both patients and physicians when considering this treatment. Below are some of the most significant contributors to treatment variability.
1. Age and Cellular Vitality
Age is a primary factor influencing the body’s regenerative capacity. As we get older, the number of mesenchymal stem cells (MSCs) in our tissues tends to decline. Furthermore, the remaining cells may exhibit reduced vitality, meaning their ability to multiply, differentiate, and secrete supportive growth factors might be less robust than in a younger individual. While treatment is possible at any age, the baseline health of a patient’s own cells can play a role in the therapeutic response.
2. Overall Health and Coexisting Conditions
Your general health status creates the environment in which the administered stem cells will function. Chronic conditions such as diabetes, cardiovascular disease, or autoimmune disorders can create a state of systemic inflammation. This pro-inflammatory environment can potentially hinder the anti-inflammatory and reparative actions of MSCs. Managing underlying health issues is an important aspect of preparing for regenerative therapy.
3. Lifestyle Choices
Daily habits have a profound impact on cellular health. Factors like smoking, excessive alcohol consumption, poor nutrition, and a sedentary lifestyle can contribute to oxidative stress and chronic inflammation, potentially diminishing the effectiveness of stem cell therapy. Conversely, a balanced diet rich in antioxidants, regular physical activity, and adequate sleep can support the body’s natural healing processes and create a more favorable environment for the stem cells to work.
4. The Nature and Severity of the Target Condition
The type, duration, and severity of the condition being addressed are also critical. Stem cells may have a different level of impact on acute injuries versus chronic, degenerative diseases that have progressed over many years. The extent of tissue damage and the level of chronic inflammation at the target site can influence how effectively the MSCs can exert their supportive effects.
Setting Realistic Expectations for Regenerative Medicine in Japan
Understanding these influencing factors is the first step toward setting realistic goals for treatment. Adipose-derived stem cell therapy is not a universal cure but a medical procedure designed to support the body’s innate ability to repair and regulate itself. In Japan, regenerative medicine is provided under a strict regulatory framework, including the Act on the Safety of Regenerative Medicine. This ensures that treatments are conducted with high standards of safety and management at licensed facilities.
It is important to note that this therapy is considered an elective treatment and is not covered by public health insurance. A comprehensive discussion with a physician is necessary to understand the full scope of the treatment, including the potential outcomes, risks, side effects, and associated costs, before making a decision.
The Importance of a Personalized Medical Consultation
Given the high degree of individual variability, a one-size-fits-all approach is not suitable for stem cell therapy. A detailed medical consultation is essential to determine if you are an appropriate candidate. During this consultation, a physician will conduct a thorough assessment of your medical history, current health status, and lifestyle. This evaluation allows the doctor to provide a personalized perspective on the potential benefits and limitations of the therapy for your specific situation. The final decision to proceed with treatment should always be based on this professional medical judgment.
Preparing for Your Consultation at Grand Green Osaka Umekita Clinic
At Grand Green Osaka Umekita Clinic, located in the heart of Osaka, we prioritize a comprehensive and individualized approach to regenerative medicine. To make the most of your consultation, we recommend preparing the following:
- A summary of your medical history, including any chronic conditions and past surgeries.
- A complete list of your current medications and supplements.
- Your specific goals and what you hope to achieve with the therapy.
- Any questions you have about the treatment process, recovery, potential risks, and fees.
This preparation will facilitate a productive discussion and help our medical team tailor a potential treatment plan that aligns with your health needs. For a comprehensive overview of our approach, including the treatment flow and frequently asked questions, please visit our Adipose-Derived Stem Cell Therapy page.
Summary: A Tailored Approach to Your Health
The outcome of adipose-derived stem cell therapy is not predetermined but is influenced by a unique combination of your age, health status, and lifestyle. By understanding these factors, you can approach the treatment with informed and realistic expectations. The key to a successful journey in regenerative medicine is a strong partnership with a knowledgeable medical team that can provide a personalized assessment and a carefully considered treatment plan. A final determination of suitability for this therapy must be made based on a physician’s diagnosis. If you are considering this option, we encourage you to schedule a consultation to discuss your individual circumstances.
- Age and Cellular VitalityCell vitality may decline with age
- Overall Health StatusChronic conditions can affect results
- Lifestyle ChoicesDaily habits impact cellular health
- Target ConditionSeverity and type of condition matter
This diagram is a conceptual summary of the article's content
References
- PubMed: Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial. (2025)
- PubMed: Human placental mesenchymal stromal cell-derived small extracellular vesicles as a treatment for severe COVID-19: A double-blind randomized controlled clinical trial. (2024)
- PubMed: Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. (2014)
- PubMed: Stem cell therapy for perianal Crohn's. (2019)
- PubMed: Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection. (2016)
- PMC: Redefining Clinical Trials on Regenerative Therapies to Target Responsiveness in Temporomandibular Joint Osteoarthritis Treatment. (2025)
- PMC: Frailty in Critical Care Medicine: A Review. (2020)
- PMC: Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy. (2022)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.